ABSTRACT
Various calcium phosphate based coatings have been evaluated for better bony integration of metallic implants and are currently being investigated to improve the surface bioactivity of polymeric scaffolds. The aim of this study was to evaluate the role of calcium phosphate coating and simultaneous delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the in vivo bone regeneration capacity of biodegradable, porous poly(propylene fumarate) (PPF) scaffolds. PPF scaffolds were coated with three different calcium phosphate formulations: magnesium-substituted ß-tricalcium phosphate (ß-TCMP), carbonated hydroxyapatite (synthetic bone mineral, SBM) and biphasic calcium phosphate (BCP). In vivo bone regeneration was evaluated by implantation of scaffolds in a critical-sized rabbit calvarial defect loaded with different doses of rhBMP-2. Our data demonstrated that scaffolds with each of the calcium phosphate coatings were capable of sustaining rhBMP-2 release and retained an open porous structure. After 6weeks of implantation, micro-computed tomography revealed that the rhBMP-2 dose had a significant effect on bone formation within the scaffolds and that the SBM-coated scaffolds regenerated significantly greater bone than BCP-coated scaffolds. Mechanical testing of the defects also indicated restoration of strength in the SBM and ß-TCMP with rhBMP-2 delivery. Histology results demonstrated bone growth immediately adjacent to the scaffold surface, indicating good osteointegration and osteoconductivity for coated scaffolds. The results obtained in this study suggest that the coated scaffold platform demonstrated a synergistic effect between calcium phosphate coatings and rhBMP-2 delivery and may provide a promising platform for the functional restoration of large bone defects.
Subject(s)
Bone Morphogenetic Protein 2/pharmacology , Bone Regeneration/drug effects , Calcium Phosphates/pharmacology , Coated Materials, Biocompatible/pharmacology , Fumarates/pharmacology , Polypropylenes/pharmacology , Skull/drug effects , Tissue Scaffolds/chemistry , Transforming Growth Factor beta/pharmacology , Animals , Delayed-Action Preparations , Female , Humans , Imaging, Three-Dimensional , Kinetics , Porosity , Rabbits , Recombinant Proteins/pharmacology , Skull/diagnostic imaging , Spectrometry, X-Ray Emission , X-Ray MicrotomographyABSTRACT
PURPOSE: To determine the efficacy supersaturated calcium phosphate (CaP) solutions containing fluoride (F) and zinc (Zn) ions in occluding dentin tubules with precipitates less susceptible to acid dissolution and to compare the performance of these solutions with the oxalate solutions containing calcium (Ca) or phosphate (P) ions. METHODS: Dentin sections from human molars divided into groups: Group A - control (treated with double distilled H2O), Groups A1, A2 and A3 were treated with experimental solutions supersaturated with respect to F and Zn-substituted calcium phosphates. Solutions A1 and A2 were similar in composition but differed in pH values (A1, pH 7; A2, pH 5.5). Solutions A2 and A3 were similar in pH (pH 5.5) but the A3 solution had twice the concentrations of F and Zn2+ ions compared to A2. Another group of dentin sections were treated with A3 solution, oxalate solution containing Ca (OX/Ca) and OX solution containing P (OX/P). The control and treated dentin sections were characterized using scanning electron microscopy. RESULTS: All treated dentin sections showed occluded dentin tubules; with the group A3 showing the highest percent of occluded dentin tubules. The precipitates in the dentin tubules treated with A3 remained while those treated with OX/Ca or OX/P dissolved after exposure to an acidic buffer.
Subject(s)
Calcium Phosphates/pharmacology , Cariostatic Agents/pharmacology , Dentin Desensitizing Agents/pharmacology , Dentin Solubility/drug effects , Dentin/drug effects , Acids , Adolescent , Adult , Apatites/pharmacology , Buffers , Calcium Chloride/pharmacology , Chlorides/pharmacology , Dentin/ultrastructure , Humans , Hydrogen-Ion Concentration , Materials Testing , Microscopy, Electron, Scanning , Oxalates/pharmacology , Phosphates/pharmacology , Potassium Compounds/pharmacology , Sodium Fluoride/pharmacology , Solubility , Young Adult , Zinc Compounds/pharmacologyABSTRACT
The mineral in bone is an impure hydroxyapatite, with carbonate as the chief minor substituent. Fluoride has been shown to stimulate osteoblastic activity and inhibit osteoclastic resorption in vitro. CO(3)- and F-substituted apatite (CFA) has been considered as potential bone graft material for orthopedic and dental applications. The objective of this study was to determine the effects of simultaneously incorporated CO(3) and F on the crystallographic physico-chemical properties of apatite. The results showed that increasing CO(3) and Na content in apatites with relatively constant F concentration caused a decrease in crystallite size and an increase in the extent of calcium release; increasing F content in apatites with relatively constant CO(3) concentration caused an increase in crystallite size and a decrease in the extent of Ca release. These findings suggest that CFAs as bone graft materials of desired solubility can be prepared by manipulating the relative concentrations of CO(3) and F incorporated in the apatite.
Subject(s)
Apatites/chemistry , Bone Substitutes/chemistry , Calcium/chemistry , Fluorides/chemistry , Absorption , Crystallization/methods , Diffusion , Hardness , Materials Testing , Particle Size , Porosity , Solubility , Surface PropertiesABSTRACT
PURPOSE: It is now well known that implant surface properties affect osseointegration. Grit-blasting with abrasives and coating by plasma are methods to modify implant surfaces. This study aimed to compare the direction of new bone formation associated with three types of surfaces. MATERIALS AND METHODS: Titanium (Ti) alloy rods grit-blasted with alumina abrasive (Group 1, G1), with apatitic abrasive (Group 2, G2), and with apatitic abrasive and plasma-sprayed with hydroxyapatite (Group 3, G3) were implanted in surgically created defects in tibias of New Zealand white rabbits for 2 and 4 weeks. After sacrifice, the implants and surrounding bones were obtained and analyzed using back scattered imaging. RESULTS: Differences in patterns of bone formation among the groups were observed: originating from the cortical bone towards the implant surface (Type A), surrounding the implant (Type B) and originating from the medullary cavity (Type C). G1 and G3 showed Types A and B while G2 exhibited Types A, B and C. After 4 weeks, greater amount of new bone was observed in G2 group compared with those in G1 and G3 groups. CONCLUSIONS: This study demonstrated that patterns of bone formation are influenced by methods of surface modification.
Subject(s)
Dental Implantation, Endosseous/methods , Dental Implants , Osseointegration , Animals , Rabbits , Scattering, Radiation , Surface PropertiesABSTRACT
PURPOSE: To test the hypothesis that anticalculus agents cannot completely inhibit calculus formation but can influence the types of calcium phosphate which form, i.e., they can influence the composition of the inorganic component of human dental calculus (HDC). MATERIALS AND METHODS: The composition of HDC specimens obtained from a 16-week multi-center clinical study using three regimens were analyzed, investigators blinded. The treatment regimens were: (a) standard dentifrice (SD), (b) pyrophosphate antitartar dentifrice, and (c) SD with Tartar Control Listerine Antiseptic mouthrinse (containing essential oils and 0.09% zinc chloride). 25 individual samples and eight pooled samples from each group were analyzed using X-ray diffraction, infrared spectroscopy, and scanning electron microscopy. RESULTS: (1) relative frequency of occurrence for: (a) bacteria: Group A = 100%, Group B = 60%, and Group C = 25%; (b) Carbonate hydroxyapatite (CHA): Groups A, B, and C = 100%; (c) dicalcium phosphate dihydrate (DCPD): Group A = 55%; Group B = 45%; Group C = 80%; (2) The relative amount of DCPD is inversely proportional to that of CHA in HDC: the higher the amount of DCPD, the lower the amount of CHA. Group C regimen with essential oil/ZnCl2 mouthrinse and standard dentifrice showed a significant anti-microbial effect and favored the formation of DCPD, the most soluble Ca-P.
Subject(s)
Chlorides/therapeutic use , Dental Calculus/chemistry , Mouthwashes/therapeutic use , Oils, Volatile/therapeutic use , Zinc Compounds/therapeutic use , Anti-Infective Agents, Local/therapeutic use , Bacteria/ultrastructure , Calcium Phosphates/analysis , Calcium Phosphates/classification , Dentifrices/therapeutic use , Diphosphates/therapeutic use , Double-Blind Method , Durapatite/analysis , Humans , Microscopy, Electron, Scanning , Organic Chemicals , Spectroscopy, Fourier Transform Infrared , X-Ray DiffractionABSTRACT
Our aims in this study were (1) to develop an electrochemical method of depositing adherent octacalciumphosphate (OCP) and other calcium phosphate coatings on titanium alloy (Ti6Al4V) substrates of different shapes and surface preparations, (2) to determine the properties of the coating (composition, morphology, thickness, dissolution), and (3) to observe transformation of OCP to carbonatehydroxyapatite (CHA) in simulated body fluid (SBF). Titanium (Ti)-alloy plates, tensile bars with four types of surfaces (grit-blasted with apatitic abrasive, chemically textured, arc-deposited, and Co-Cr-beaded) and dissolution cylinders were electrochemically coated with the use of modulated pulse time electric fields programmed with a custom-made dual microprocessor. Modulated electrochemical deposition (MECD) was carried out with pH and temperature conditions favorable for OCP formation. Coatings were characterized using X-ray diffraction, FT-IR, scanning electron microscopy, tensile strength tests, and solubility tests. XRD and FT-IR analyses showed that pure, uniform OCP coatings were produced on Ti6Al4V surfaces with coating-to-substrate tensile strengths greater than 7,000 psi. Coatings on Ti arc-deposited surfaces, chemically textured surfaces, and Co-Cr-beaded surfaces all gave tensile strengths ranging from 5,000 to 7,000 psi, with no coating shadows in the crevices. Dissolution of OCP coating in 100 mL of 0.1 M Tris buffer solution was determined from the amount of calcium (Ca) released onto the buffer, which was 7.7 +/- 1.0 ppm Ca at pH 7.3 after 4 h, and 22 -/+ 1.4 ppm Ca at pH 3 after 2 h. We found that OCP crystal size can be controlled by the current density and relative pulse time modulation. Our study demonstrated the following: (1) Highly adherent calcium phosphate (e.g., OCP) coating of uniform compositions (e.g., OCP) on Ti-alloy substrates can be obtained at low temperatures with the use of MECD by optimizing pulse time modulation of the electric field, reaction pH, temperature, and electrolyte composition; and (2) OCP readily transforms to CHA when exposed to SBF.